Report provides comprehensive look at financial and accounting issues faced by life sciences industry.
On Mar. 16 Deloitte released its 12th annual Life Sciences Industry Accounting Guide. The report provides a comprehensive look at some of the complex issues that finance and accounting professionals in the life sciences industry face including R&D costs, acquisitions and divestitures, consolidation, contingencies, revenue recognition, income taxes, financial instruments, and financial statement presentation and disclosure.
Some of the main themes from this year’s edition include:
Advertisement
COVID-19-Related Accounting and Financial Reporting Considerations for Life Sciences Entities
IPOs and SPACs
Revenue Recognition
Structured Trade Payable Arrangement
For additional information and the full report, click here.
